Front Page

World-leading gaming and immersive technology companies based in the West Midlands are being backed by Mayor Richard Parker to help modernise health services and get more people back into work. The first-of-its-kind XR (Extended Reality) Health and Wellbeing Hub is one of eight regional projects being supported in the latest...

Blüm Health is proud to announce that it has been awarded the Breakthrough – North West & North Wales accolade at the The Spectator Economic Innovator of the Year Awards 2025. Blüm Health stood out among a competitive field of regional finalists for its cutting-edge work in digital health solutions....

Medilink Midlands is delighted to welcome Abigail (Abi) Phillips to the team as Delivery & HTC Programme Manager, further strengthening the organisation’s capacity to deliver impactful programmes and drive collaboration across the region. Abi joined in November 2025 and brings a strong background in managing programmes and building partnerships across...

IMed Group, a leading provider of expert services to the global medical and health technology industry, is pleased to announce the appointment of Parminder Kalle as its new Chief Commercial Officer. Parminder brings over 20 years of experience across medical devices, in vitro diagnostics (IVDs), Pharma and digital health, combining...

The inaugural East Midlands Life Sciences Summit took place this week at Charnwood Campus, Science, Innovation and Technology Park, bringing together over 150 leaders from industry, academia, and the NHS to explore how the region can help the UK deliver on its Life Sciences Vision and Strategy. Themed “Scaling for...

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters at Charnwood Campus Science Innovation and Technology Park, Loughborough. The facility represents a significant expansion in Kindeva’s MDI services and will develop and test next-generation propellants (NGP) as the industry prepares to move to more...

In a significant move for the global medtech landscape, the European Commission has initiated a targeted revision of the Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR). This response to widespread calls from the medtech sector aims to streamline regulatory processes, cut costs, and expedite market...

Inaphaea BioLabs, the wholly owned translational Contract Research Organisation of ValiRx Plc, has announced a series of major initiatives over the past three months that significantly advance its role in translational cancer research, drug discovery, and personalised medicine. Under the leadership of Mark Eccleston, the recently appointed CEO of parent...

Following the delivery of its first cohort and strong demand for Cohort 2, Medilink Midlands is now welcoming applications for Cohort 3 of its venture readiness programme, the Medilink Midlands Innovation Builder (MMIB), launching in early 2026. MMIB has quickly become a valued route for health and medtech innovators to...